Conjoined Twins From Mali Given New Lease of Life at Sidra Medicine, Qatar

Food and Healthcare Press Releases Thursday October 11, 2018 08:00
DOHA, Qatar--11 Oct--PRNewswire/InfoQuest

Doctors at Qatar's first specialist women's and children's hospital Sidra Medicine have successfully separated conjoined twins, marking a first for the country. The surgery establishes an alternative for patients who previously had limited choices for the successful treatment and care of complex pediatric diseases in the region.

To view the Multimedia News Release, please click: https://www.multivu.com/players/uk/8422651-conjoined-twins-find-new-lease-on-life/

The twins were conjoined at the liver and lower sternum - considered one of the riskier types of fusion, as each baby needs a fully functional liver of their own without compromising the other. Globally, conjoined twins occur once in about every 200,000 births. Omphalopagus twins, those who are connected at the belly and liver, are some of the most complex to separate.

Led by Dr. Mansour Ali, Chair of the Department of Pediatric Surgery and Dr. Abdalla Zarroug, Division Chief of Pediatric General and Thoracic Surgery, the four-month-old male twins were separated by a team of 10 surgeons and anesthesiologists, during a nine-hour procedure.

"By successfully separating conjoined twins, one of the most complex surgical procedures there is, we are proud to showcase the calibre of our multidisciplinary teams just a year since we opened our inpatient facility. The surgery is both a milestone for the hospital and healthcare in Qatar," said Dr. Mansour.

Less than 10 days after separation, Hamad and Tamim are recovering and expected to live normal, independent lives.

"Combined with access to the latest technology to support pre-surgical planning and delivery, we have the advantage of having some of the world's top pediatric specialists in general and thoracic surgery, urology, craniofacial, plastics, anesthesiology and robotic surgery. The fact that we are able to use these resources to offer pediatric surgical services that did not exist in the region before, is the reason we are here," said Dr. Zarroug.

The surgery was planned and rehearsed for months with a full complement of over 150 medical and support staff undergoing over 30 hours of simulation to minimize the risks and improve patient outcomes. Sidra Medicine's state-of-the-art 3D printing technology helped create a model of the boys' abdomen and liver to assist with pre-surgical planning.

The father said: "We tried to explore international options for surgery until we found out about Sidra Medicine. We are immensely grateful to the Government of Qatar, Hamad Medical Corporation and Sidra Medicine for their tireless efforts to save the lives of our boys."

Farhana Habib
Public Relations
t. +974-4404-2176
m. +974-7478-4648
fcoelho@sidra.org
Photo: https://mma.prnewswire.com/media/766865/Sidra_Medicine.jpg
Source: Sidra Medicine

Latest Press Release

Mallinckrodt Announces Interim Analysis Results for Therakos(R) Platform Phase 3 Clinical Trial in Treatment of Pediatric Patients with Steroid Refractory Acute Graft-versus-Host Disease

-- Overall response rate exceeded specified study midpoint target (n=25); company elects to discontinue further patient enrollment as allowed by protocol -- Mallinckrodt plc (NYSE:MNK), a leading global specialty pharmaceutical company, today announced...

Takeda, Microsoft and EURORDIS release report with action plan to help rare disease community shorten the diagnostic odyssey

- Global Commission's recommendations focus on three solution pathways that leverage technology to address key elements of the rare disease diagnostic odyssey - Rare diseases remain undiagnosed as patients struggle to navigate complex health systems to...

Pivotal Phase III Data for BAVENCIO(R) (avelumab) Plus INLYTA(R) (axitinib) in Advanced Renal Cell Carcinoma Published in the New England Journal of Medicine

- JAVELIN Renal 101 shows significant improvement in progression-free survival with a hazard ratio of 0.69 in patients regardless of PD-L1 expression - US FDA has granted Priority Review to BAVENCIO plus INLYTA for patients with advanced renal cell...

ISABS เตรียมจัดการประชุมว่าด้วยการแพทย์ส่วนบุคคลที่โครเอเชีย พร้อมเชิญเจ้าของรางวัลโนเบลร่วมบรรยาย

International Society for Applied Biological Sciences (ISABS) ร่วมกับ Mayo Clinic และ St. Catherine Hospital เตรียมจัดการประชุม "ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine" ครั้งที่ 11...

ISABS: Personalized Medicine Conference With Nobel Laureates to Be Held in Split, Croatia

International Society for Applied Biological Sciences (ISABS), Mayo Clinic and St. Catherine Hospital are organizing "11th ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine"(http://www.isabs.net)...

Related Topics